We welcome you to the 5th Miami Thyroid Oncology Symposium to discuss the rapidly expanding science of "Molecular Theranostics". Our approach to thyroid nodules and thyroid cancer has expanded beyond conventional diagnostics and therapeutic interventions. A broad catalog of genomic and epigenomic markers associated with thyroid cancer is now available and is in clinical use. The risk stratification systems that are critical for initial surgical treatment and subsequent use of radioactive iodine treatment rely more and more on distinct molecular markers, and less on traditional parameters. Genomics with molecular pathology and molecular imaging reflect the true biologic nature of the different cancer types currently defined by conventional morphologic features, The tumor differentiation/de-differentiation and clinical behavior for each individual cancer are now being defined by molecular characteristics, in addition to standard histopathology.
The 2022 Miami Thyroid Oncology Symposium
13499 Biscayne Boulevard, Suite 102, North Miami, FL 33181